Chipiron: Funding, Investors & Team (Sep 2026)
Leveraging cutting-edge quantum detectors, we design light, portable, and performing MRI machines working at ultra-low magnetic fields for a tenth of current prices.
Chipiron has raised $1.2M across 1 funding round on record, the most recent an undisclosed round of $1.2M announced in Apr 2024.
That round is below the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Chipiron Company Profile and Key Stats
Latest funding round on record: Apr 2024.
Chipiron Funding Rounds
Chipiron Founders and Leadership Team
No contact details are on record for this team yet.
Chipiron Funding Compared to Other Health Care Startups
Chipiron's latest round of $1.2M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Chipiron in Health Care and Paris
Companies Similar to Chipiron
Beams is a producer of medical devices for cancerology based on the use of particles β.
Padoa is an occupational health software firm that develops a tool for monitoring the health of employees.…
CILcare specializes in providing drug solutions for hearing and ear disorders.
MEDIAN Technologies develops medical imaging software and services dedicated to oncology clinical trials,…
noa is a digital fitness and wellness company that offers premium, structured training programs for strength,…
Semeia offers patient monitoring solution designed to support medical followup of patients, remotely and in…
Signadori Bio is the next-generation cellular immunotherapy for cancer cure.This has culminated in the…
Axomove is an e-wellbeing application that spends significant time in video actual activities.
Parallel helps coding agent works side by side with hospital teams to deliver faster and more accurate…
May Health has created a new solution for infertility caused by Polycystic Ovary Syndrome (PCOS) that is…
MedinCell is an injectable slow-release drug specialist company.
Charles helps men regain control over their daily health concerns by starting with their personal health.
Chipiron Funding FAQs
What does Chipiron do?
Leveraging cutting-edge quantum detectors, we design light, portable, and performing MRI machines working at ultra-low magnetic fields for a tenth of current prices.
How much funding has Chipiron raised?
Chipiron has raised $1.2M across 1 round on record. The most recent is an undisclosed round of $1.2M announced in Apr 2024.
When did Chipiron last raise funding?
Chipiron's most recent funding round on record is an undisclosed round of $1.2M, announced in Apr 2024.
Who founded Chipiron?
FundedIQ lists Damien Marly (Founder) at Chipiron.
Where is Chipiron headquartered?
Chipiron is based in Paris, Ile-De-France, France.
How many employees does Chipiron have?
Chipiron is in the 11-50 employee band.
How does Chipiron's funding compare to other Health Care startups?
Chipiron's latest round of $1.2M is below the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Chipiron Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Chipiron is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.